You just read:

Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder

News provided by

Marinus Pharmaceuticals, Inc.

Apr 21, 2011, 08:00 ET